SCHEMBL737638

SCHEMBL737638

OC1(CNC2CC2)CCN(c2ccc(OCc3ccccc3)cc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.46
NPC1 O15118 2/20 0.46
MAPT P10636 4/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
KDM4E B2RXH2 2/20 0.45
KMT2A Q03164 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
FOXM1 Q08050 1/20 0.44
MEN1 O00255 1/20 0.43
HRH3 Q9Y5N1 3/20 0.43
ACACB O00763 1/20 0.42
KDM1A O60341 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
LTA4H P09960 1/20 0.41
BCHE P06276 1/20 0.41
PRMT5 O14744 1/20 0.41
GRIN1 Q05586 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4940044 0.96 KDM4E (0.51) RAB9ANPC1MAPTALDH1A1LMNA
SCHEMBL735913 0.96 KDM4E (0.48) RAB9ANPC1MAPTALDH1A1LMNA
SCHEMBL736957 0.95 KDM4E (0.50) RAB9ANPC1MAPTALDH1A1LMNA
SCHEMBL737726 0.81 MAPT (0.48) RAB9ANPC1MAPTALDH1A1LMNA
SCHEMBL737545 0.79 MAPT (0.50) RAB9AMAPTALDH1A1LMNAHTT
SCHEMBL7902701 0.76 FOXM1 (0.53) MAPTALDH1A1LMNAHTTKDM4E
SCHEMBL17888549 0.75 RAB9A (0.68) RAB9ANPC1MAPTALDH1A1LMNA
SCHEMBL27940735 0.75 MAPT (0.46) RAB9ANPC1MAPTALDH1A1LMNA
SCHEMBL4940466 0.74 MAPT (0.42) RAB9ANPC1MAPTALDH1A1LMNA
SCHEMBL5702290 0.74 ALDH1A1 (0.47) RAB9ANPC1MAPTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138206-B2 Piperidine derivative MSD. K.K. (JP) 2012-03-20 US disclosed
US-20090137576-A1 Novel Piperidine Derivative MSD K.K. (JP) 2009-05-28 US disclosed
CN-101228127-A Novel Piperidine Derivatives BANYU PHARMA CO LTD (JP) 2008-07-23 CN disclosed
EP-1892241-A1 NOVEL PIPERIDINE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. (JP) 2008-02-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137576-A1 Novel Piperidine Derivative HRH4, HRH3, HRH1 RAB9A 2876/4885NPC1 3252/4885MAPT 4377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.